Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03063918 · ClinicalTrials.gov registry record · NA

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

A NA study of Cancer Survivor and Stage I Rectosigmoid Cancer, sponsored by City of Hope Medical Center.

Completed
Registry status
NA
Development phase
10
Enrollment target
2
Study locations

NCT03063918: Completed NA study of Cancer Survivor and Stage I Rectosigmoid Cancer, sponsored by City of Hope Medical Center.

NCT03063918 is a NA study of Cancer Survivor and Stage I Rectosigmoid Cancer that has completed, run by City of Hope Medical Center. The registered enrollment target is 10 participants, below the 266-participant average among 25 other Cancer Survivor trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03063918, a NA study of Cancer Survivor and Stage I Rectosigmoid Cancer, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

This pilot clinical trial studies how well personalized dietary intervention works in managing bowel dysfunction and improving quality of life in stage I-III rectosigmoid cancer survivors. Personalized dietary intervention may help people understand bowel symptoms, identify helpful and troublesome foods for bowel symptoms, adjust diets and food preparation based on food triggers, and coach on healthy diet recommendations after cancer treatment.

Primary Outcome

Will be assessed through qualitative data analysis using conventional content analysis approach.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Survey Administration
  • OTHER Questionnaire Administration
  • OTHER Informational Intervention
  • BEHAVIORAL Telephone-Based Intervention

Study Locations (2)

Arizona

  • The University of Arizona Medical Center-University Campus - Tucson

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-04-28
Est. Completion 2021-09-07
Phase NA
City of Hope Medical Center

582 total trials

What the finished NCT03063918 record still lists

NCT03063918 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 266-participant average among 25 other Cancer Survivor trials with a reported enrollment target (96% lower).

The record links to 4 conditions, with Cancer Survivor appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.

NCT03063918 reports a single indexed study location in Arizona, California.

Frequently Asked Questions

What is clinical trial NCT03063918 about?

NCT03063918 is a clinical study titled "Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors". This pilot clinical trial studies how well personalized dietary intervention works in managing bowel dysfunction and improving quality of life in stage I-III rectosigmoid cancer survivors. Personalized dietary intervention may help people understand bowel symptoms, identify helpful and troublesome f...

What is the current status of trial NCT03063918?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-04-28. Estimated completion is 2021-09-07.

What conditions does trial NCT03063918 study?

This clinical trial studies the following conditions: Cancer Survivor, Stage I Rectosigmoid Cancer, Stage II Rectosigmoid Cancer, Stage III Rectosigmoid Cancer.

What interventions are being tested in trial NCT03063918?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Survey Administration (OTHER), Questionnaire Administration (OTHER), Informational Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03063918?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03063918 being conducted?

This trial has 2 study locations across Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Survivor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03063918's enrollment target sits among peer trials

10 25th of 25 higher than 1 of 25 other Cancer Survivor trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer Survivor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03063918, the US trial registry maintained by the National Library of Medicine. NCT03063918 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.